Current Edition

Reimagining the Pharmaceutical Life Cycle with Artificial Intelligence

From discovery to clinical trials, to marketing and managing medicinal products on the market, artificial intelligence (AI) is delivering promise and possibility to the life sciences industry. Intricate, timeconsuming tasks that once took departments weeks, months, or even years to accomplish are now being reimagined, thanks to AI and other digital technologies. Marco Anelli, Product Life Group, identifies how once a product reaches clinical trials, AI-type technologies can be engaged to reduce time, costs, and resources, including test subjects.